Determination of pyrimidine 5'-nucleotidase (P5N) activity in whole blood as an index of lead exposure.
A simple method for determining pyrimidine 5'-nucleotidase (P5N) activity in whole blood has been developed, inhibiting the plasma activity for UMP-hydrolysis by concanavalin (Con A). Con A specifically inhibits the activity of plasma 5'-nucleotidase (5N) but does not affect erythrocyte P5N activity...
保存先:
| 出版年: | Br J Ind Med |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
1988
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1009621/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2840110/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/oem.45.6.420 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|